Historical Fellowship

NHS Innovation Accelerator Fellowship 2027: Historical Reference for the Closed Intake

Historical reference for the closed 2027 intake of the NHS Innovation Accelerator, a three-year programme for innovators with proven health or care solutions. The official page says applications are closed and directs prospective applicants to watch for next year’s opportunity.

FindMyMoney.App
Published by FindMyMoney.App
Official source: NHS Innovation Accelerator
đź’° Funding No individual cash award stated
đź“… Deadline Historical reference
📍 Location England, United Kingdom and International applicants welcome
🏛️ Source NHS Innovation Accelerator

NHS Innovation Accelerator Fellowship 2027: Historical Reference for the Closed Intake

This page records the NHS Innovation Accelerator (NIA) 2027 intake for reference. The official application page now says applications for the 2027 Fellowship have closed and invites innovators interested in applying next year to follow the programme and useful resources. It does not yet publish an opening date or deadline for a subsequent intake. No new cycle date should be inferred from the 2027 calendar below.

The 2027 recruitment opened on 17 August 2026. Applicants needed to start the Readiness Check by 12:00 noon on Friday 25 September 2026, then complete the invited Main Application by 23:59 on Sunday 27 September 2026. Both dates have passed. The call planned to recruit up to 24 new Fellows for the 2027 intake. It described a structured programme lasting up to three years, with tailored advice, expert mentors, access to NHS and Health Innovation Network connections, peer learning, showcase opportunities, and practical help with adoption. The official call, Key Dates document and FAQs do not state a standard individual cash award or stipend; programme funding should not be read as salary replacement or unrestricted grant money.

Key details

DetailInformation
OpportunityNHS Innovation Accelerator Fellowship, 2027 intake
StatusClosed; official page directs prospective applicants to watch for next year’s opportunity, but gives no next-cycle dates
Funder and delivery partnersFunded by NHS England; delivered by UCLPartners with the 15 Health Innovation Networks
PlacesUp to 24 new Fellows
Best fitIndividuals representing validated innovations ready to scale across the NHS
SupportMentoring, tailored advice, learning events, NHS connections, visibility, peer network and scale-up guidance
Cash awardNo standard stipend or award amount is confirmed in the 2027 call documents
Applications opened17 August 2026
Readiness Check deadlineStart by 12:00 noon, 25 September 2026
Main application deadline23:59, 27 September 2026
Programme startMarch 2027 launch, with formal activity beginning in spring 2027
CommitmentApproximately two days each week, plus mandatory events and reporting
Official application pageNHS Innovation Accelerator application page

What the Fellowship offers

The NIA exists to help proven innovations move through the difficult part between successful testing and broad adoption. A product can work in one hospital and still face major barriers when another NHS organisation considers buying, deploying, integrating or commissioning it. The programme focuses its support on those barriers: building a persuasive business case, identifying decision-makers, understanding procurement, developing partnerships, improving communication, and adapting the implementation plan to different settings.

The 2027 call describes a structured three-year programme. Year 1 includes quarterly events and learning sessions on subjects such as procurement, communications, behavioural science, and legal or intellectual-property issues. Fellows can also receive introductions, specialist advice and signposting to relevant expertise. The programme connects Fellows with all 15 Health Innovation Networks, as well as national bodies, professional networks, innovators and NHS leaders. The exact support package is tailored to each Fellow’s innovation, objectives and stage of development.

There is also a visibility and peer-learning component. Fellows may present at regional or national events and contribute insights to policy and strategy discussions. A growing community of Fellows and alumni provides a place to compare adoption problems and share practical lessons. These benefits are valuable for an organisation that needs NHS relationships and implementation knowledge, but they are not a promise of procurement, sales, investment or a particular number of NHS deployments.

The opportunity is delivered by UCLPartners in partnership with NHS England and the Health Innovation Networks. The call says the programme is funded by NHS England and that all 15 networks provide direct financial support and governance to the programme. That description concerns operation of the NIA; it does not confirm that every Fellow receives a separate cash payment. Budget for staff time, travel, regulatory work and implementation should therefore be planned independently.

Who should apply

For the 2027 intake, the NIA awarded the Fellowship to one individual representing an innovation. That person could be its inventor, organisational lead, or another representative with enough influence to shape adoption and spread. Teams and partners could support the work, but each application had to name one applicant; the applicant section was to be written in the first person.

The 2027 call welcomed applicants from public bodies, universities and research institutions, charities, social enterprises, community organisations, small and medium-sized enterprises, and large companies. Clinicians, administrators, social workers, entrepreneurs and other healthcare professionals could fit when they had a meaningful role in taking the innovation forward. International companies could apply, and the FAQ said the company did not have to be UK-based. However, applicants were expected to be mainly based in the UK because several activities were in person, and an international innovation ideally already had some UK presence.

The 2027 call sought more than a good product story. It asked applicants to show communication and collaboration, a learning mindset, an external orientation, an entrepreneurial approach, and strong values. Applicants needed to be able to work with patients, carers, communities, clinicians, commissioners and system leaders. Their organisation needed to support the Fellowship place and the approximately two-day-per-week commitment. Without that support, even a strong innovation could be a poor fit.

What counts as a suitable innovation

The 2027 NIA call targeted the transition-to-scale stage. It was not intended for a concept, an early prototype, or a project whose main purpose was to generate initial research findings. Innovations were expected to have been tested through pilots, clinical trials or other real-world settings and to have a robust evidence base showing measurable improvement in outcomes or meaningful direct or indirect health impact.

The call expected an innovation to have been deployed in an NHS or care setting in the UK or internationally, with an exception for environmental or climate-focused innovations not yet implemented in a health setting. It needed to be ready for further NHS adoption, financially viable, and supported by a credible scale pathway. Applicants had to consider intellectual property, regulation, ethics and information governance. Digital innovations needed interoperability with core NHS systems. The NIA excluded early-stage or primarily research-focused work, drug-dose or clinical-administration testing, research into the causes or treatment of illness, and interventions primarily focused on education or training.

The 2027 focus areas include access, productivity, Modern Service Framework priorities and women’s health. Examples include digital triage, remote consultations, urgent-care routing, NHS App and data-platform integration, community diagnostics, predictive prevention, ambient documentation, discharge management, workforce planning, medicines optimisation, virtual wards, mental health, cardiovascular disease, sepsis, dementia, children’s health, menopause support, maternity safety and clinical-trial participation. These are priority signals rather than a substitute for evidence. An innovation outside the examples may still be relevant if it addresses a current NHS need and demonstrates a convincing case for adoption.

Evidence and eligibility checklist

For the 2027 application, the call’s checklist asked applicants to show the problem an innovation addresses, why current practice is insufficient, and how the solution improves care or system performance. Evidence needed to go beyond testimonials. Useful material included before-and-after outcomes, controlled or comparative results where available, implementation data, patient-reported outcomes, waiting-time or capacity measures, cost or health-economic analysis, adoption records, and documented feedback from users and purchasers.

Patient and public involvement was central to the 2027 call. Applicants were asked to explain how patients, carers or communities had shaped the innovation and would continue to influence its development and rollout. The application was to address health inequalities directly: which groups could benefit, which could be excluded or harmed, and what design or implementation choices could reduce that risk. For digital solutions, it asked applicants to explain accessibility, data exchange and deployment requirements rather than rely on a general claim of scalability.

The application also needed to make the applicant’s role clear: decisions they had made, partnerships they had built, and barriers they had handled. Applicants were encouraged to identify colleagues and partners with complementary expertise in stakeholder engagement, business cases, adoption strategy, change management, commercial work, regulation or implementation. The Fellowship was awarded to an individual, while the NIA expected that person to work through a wider team.

How the application works

The first step for this closed intake was the online Readiness Check, intended to test fit before applicants spent time on the full form. The NIA aimed to review it and respond within three working days. The check had to be started by noon on 25 September 2026. Applicants meeting the criteria were invited by email to complete the Main Application.

The Main Application deadline was 23:59 on 27 September 2026; the call said late applications would not be accepted. Its required components were the application form, authorisation from the employing organisation, two references, and additional supporting information where relevant. Applicants were directed to read the 2027 Call for Applications, Key Dates document and FAQs, and to review the draft Fellowship contract and Code of Conduct, which the successful applicant and organisation would need to sign in final form.

Under the 2027 process, the NIA team screened submitted applications for completeness, a single named lead, sufficient innovation maturity, the two-day commitment, evidence of impact, and use in at least one health or social care site. At least five assessors drawn from patient, clinical, commercial and implementation backgrounds scored the applicant and innovation sections. Applications needed at least 65% in each section to be offered an interview. NICE and NHS England could informally review shortlisted applications, particularly for guideline alignment, evidence concerns and fit with NHS direction.

Under that process, successful interviewees received conditional places subject to due diligence. References were checked, intellectual-property arrangements confirmed, information-governance checklists completed, and attendance at compulsory dates verified. A final unconditional offer and signed contracts followed successful due diligence. Unsuccessful applicants at assessment and interview stages were to receive written feedback.

Closed 2027 timeline and time commitment

The application window ran from 17 August to 27 September 2026. According to the official call, assessment was scheduled for 5 October to 6 November, with a shortlisting panel on 24 November and interview invitations on 25 November. Interviews were scheduled for 6 to 15 January 2027. The final decision panel was scheduled for 4 February, with outcomes communicated on 5 February and feedback due by 26 February.

The published schedule placed due diligence and onboarding between 8 February and 5 March 2027, with onboarding documents due by 19 February. The mandatory programme calendar then listed induction on 9 March, a launch dinner on 15 March (marked provisional in the call), a launch event on 16 or 17 March, and a panel day on 20 April. Year 1 quarterly events were listed for May, July and October 2027, followed by a March 2028 quarterly event. Learning events were listed for June and September 2027 and February 2028.

Fellows in the 2027 cohort were expected to commit about two days per week to scaling the innovation and participating in NIA activity. For some, this could be part of an existing role; clinicians might need to arrange protected time alongside other duties. Attendance at mandatory sessions was required. Fellows were also expected to participate in the learning programme, share experience with peers, report progress quarterly, contribute to evaluation, and demonstrate continuing engagement. Progression from Year 1 into Years 2 and 3 depended on meeting programme requirements and making reasonable progress.

How to prepare a competitive application

For a future call, a useful first preparation step is a one-page evidence map: state the unmet need, affected population, intervention, setting, measurable result, and next adoption decision. Attach a source to every material claim. If the evidence is observational, say so. If a result comes from one site or a small cohort, define the boundary instead of presenting it as NHS-wide proof.

A future application could then build an adoption plan for a real NHS buyer or partner. Name decision-makers, procurement route, implementation dependencies, workforce implications, integration work and likely objections. Include the financial case where possible: costs avoided, capacity released, staff time saved, patient benefit, or the cost of maintaining current practice. A strong plan connects evidence to a specific scaling decision rather than describing growth in abstract terms.

For a later round, use the patient and equity sections to show work already done: who was involved, what changed because of their input, and how different outcomes will be monitored across groups. Check that regulatory, ethical, data-protection and intellectual-property arrangements are current. Ask the employer for written authorisation early, confirm references, and reserve every compulsory date published for that cohort.

Common mistakes to avoid

The 2027 call was not designed for an idea without real-world deployment. It looked for innovations already used in health or care and ready for wider adoption; market interest, a prototype demonstration or a research plan alone did not replace real-world evidence.

The 2027 application was about the individual as well as the organisation. Applicants were expected to explain what they led, how they made decisions, and how they learned from partners, while identifying the team, NHS partners and specialist capabilities that made delivery credible.

A priority area was not automatic eligibility in the 2027 call. An innovation involving AI, interoperability or women’s health still needed evidence, patient benefit and a workable NHS route. NIA connections did not guarantee procurement or national adoption.

The 2027 process had separate Readiness Check and Main Application deadlines, with the latter available only after invitation; its documents said late applications would not be accepted. For any future round, prepare early and follow the new call’s schedule and instructions.

Frequently asked questions

Is this a cash scholarship or grant?

No standard Fellow stipend or cash award is stated in the 2027 call. It is best understood as a funded, three-year support programme for innovators, with mentoring, networks, learning, visibility and tailored scale-up assistance. Confirm any employment, travel or project-cost arrangements directly with the NIA before relying on them.

Must the company be based in the UK?

No. The FAQ says overseas applicants and companies can apply. The applicant should be mainly based in the UK because key events are in person, and the innovation should ideally have some UK presence. An international company that is only beginning to enter the NHS may need to build local relationships first.

Can a clinician or charity apply?

Yes. The call welcomes public-sector applicants, clinicians, universities, charities, social enterprises, community organisations, SMEs and large corporates. The deciding issue is whether the person represents a validated innovation and can influence its adoption and scale.

How many people from one team can be Fellows?

Each application names one Fellow. The applicant can describe the roles of colleagues and partners, and some events may include the wider team, but the Fellowship commitment belongs to the named individual.

What should I do if the innovation is not ready?

The 2027 call said that applicants found ineligible at the Readiness Check would receive signposting and guidance about possible next steps and other support. For a future cycle, use its own readiness criteria: the 2027 profile is useful background, but it does not establish future eligibility.

Official sources and future-cycle note

The official NHS Innovation Accelerator application page is the source to check for the live programme status and future recruitment information. It currently records the 2027 Fellowship as closed and says that people interested in next year should use its programme information and resources. The retained 2027 Call for Applications, Key Dates document, and 2027 FAQs document that past cohort. For a later round, confirm the opening date, eligibility, time commitment, award details, application steps and required documents in its own call before relying on anything on this archive page. Historical questions about the 2027 intake may be directed to [email protected].

The next useful step for a prospective applicant is to monitor the NIA’s official application page for an announced call. The 2027 materials remain useful for understanding the programme’s purpose and past selection approach, but they do not announce another intake or promise that its terms will stay the same. In that future call, check whether the innovation stage, evidence threshold, priority themes, organisational support requirements, in-person attendance and weekly commitment fit the applicant and the organisation. Build a current evidence map around the need, users, deployment, outcomes, health economics, equity effects and adoption barriers. Confirm permission for protected work time, assemble references and relevant supporting evidence, and plan for the actual dates and documents published by NIA. Until the programme posts that information, this page remains a historical account of the 2027 opportunity, not an open application listing.

Next step
Check official source